Cannabis

The Sept. 25 charter amendment doubles common-share capacity and raises the cannabis landlord’s preferred-share ceiling without a shareholder vote.

The Sept. 25 meeting lacked quorum, leaving shareholders until 9 a.m. EDT on Oct. 23 to submit proxies before the reconvened vote.

Holders will weigh a new parent company, a Delaware move and a voting-share sunset extension as Cresco pursues a potential U.S. listing.

Curaleaf urged a signature on Sept. 23; A10698B would let regulators seek suspensions and impose daily civil penalties.

Aurora cites missing pro forma financials, a French-language notice and the mandatory 105-day deposit period in its ASC application.

Advisers voted 10 to 0 on safety and 6 to 4 on effectiveness; the FDA has not set a date for its final decision.

A 51 per cent stake in a Polish drone company remains a non-binding proposal, while the registered share sale is expected to close Sept. 24.

The Health Canada-authorized depression study plans to enroll up to 200 people, while the batch also serves Australian clinics.

The addition gives Curaleaf a second Canadian benchmark, but its Sept. 23 release does not quantify any resulting fund purchases.

Vanguard's Extended Market Index Fund, which held US$95.4 billion on Aug. 31, tracks one of the two benchmarks that took the shares in.

GROW Group will distribute the Kincardine-grown flower in Britain under Canopy's Spectrum Therapeutics medical brand.

The Under New Ownership campaign went up on Sept. 21, and Tilray says it has reopened 16 BrewDog bars since the takeover closed.

He tried to swindle his store out of US$875 worth of product

The devastating blast came one week after a local fire marshal ordered it be shut down

Britain's medical cannabis sector has been rapidly expanding

Shares rose by 18% on the TSX when the financials dropped

If successful, the combined firm would be worth about US$3 billion

Illinois laws coming into force later this year could limit their sale to strictly dispensaries

New York will have a dedicated booth for the first time this year

A legal representative said they will appeal against the ruling

NZX-listed Rua Bioscience will get the equivalent of US$5.8M over the next two years

The nation's legal sector is small and growing slowly

Shares started trading on the major equity market Jun. 30

Financial terms of the deal were not disclosed

Seattle will be hosting two games in early July

A flourishing illicit market is one of the primary reasons C3 cited

It's too appealing to children, according to the government

The first patients to receive state-approved marijuana were veterans and a lady with MS

This 'FutureCave' project will use over 80 tonnes of Australian-grown hemp and straw

CEO Kim Rivers was instrumental in getting Trump to issue an executive order for rescheduling

The state legalised over 5 years ago but legal hurdles caused a long delay

The regulatory process has been dragging on for far too long

This is the 3rd year that the media company's event has been held

The DOJ says that the MSO received an 'erroneous' refund and wants interest too

Veri will be offering 3.75 million common shares at US$4 apiece

The firm described AKAN as a 'half-baked cannabis company where shareholders get smoked'

The change came into force on May 1

Local officials found over 110 kilos of Kush -- the largest drug bust ever at the Colombo terminal

State-licensed medical cannabis is now a Schedule III substance

Over the past six years, Trupanion has recorded more than 1,800 cannabis-related toxicity claims nationwide